Black Rock Inc. Harrow Health, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Harrow Health, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,182,758 shares of HROW stock, worth $47.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,182,758

Previous 2,220,538 1.7%

Holding current value

$47.2 Million

Previous $24.9 Million 16.11%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$9.3 - $13.23 $351,354 - $499,829	-37,780 Reduced 1.7%	2,182,758 $28.9 Million
Q4 2023 Feb 13, 2024	BUY	$8.1 - $16.36 $1.55 Million - $3.13 Million	191,440 Added 9.43%	2,220,538 $24.9 Million
Q3 2023 Nov 13, 2023	BUY	$14.03 - $22.08 $3.36 Million - $5.29 Million	239,716 Added 13.4%	2,029,098 $29.2 Million
Q2 2023 Aug 11, 2023	BUY	$17.37 - $28.08 $22.5 Million - $36.3 Million	1,293,806 Added 261.07%	1,789,382 $34.1 Million
Q1 2023 May 12, 2023	BUY	$13.84 - $21.46 $672,056 - $1.04 Million	48,559 Added 10.86%	495,576 $10.5 Million

Q4 2022 Feb 13, 2023	BUY	$10.28 - $14.78 $123,668 - $177,803	12,030 Added 2.77%	447,017 $6.6 Million
Q3 2022 Nov 14, 2022	SELL	$6.57 - $24.88 $11,109 - $42,072	-1,691 Reduced 0.39%	434,987 $5.25 Million
Q2 2022 Aug 12, 2022	BUY	$5.75 - $7.74 $862 - $1,161	150 Added 0.03%	436,678 $3.18 Million
Q1 2022 May 12, 2022	BUY	$6.77 - $8.66 $35,616 - $45,560	5,261 Added 1.22%	436,528 $2.98 Million
Q4 2021 Feb 10, 2022	BUY	$8.5 - $12.0 $139,238 - $196,572	16,381 Added 3.95%	431,267 $3.73 Million
Q3 2021 Nov 09, 2021	BUY	$6.99 - $10.6 $7,136 - $10,822	1,021 Added 0.25%	414,886 $3.77 Million
Q2 2021 Aug 11, 2021	BUY	$6.68 - $11.07 $2.76 Million - $4.58 Million	413,865 New	413,865 $3.85 Million

Others Institutions Holding HROW

# of Institutions

123

Shares Held

21.3M

Call Options Held

113K

Put Options Held

366K

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $586M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account